Latest Data & Signals Issued

Below are some of the latest signals issued for NextCure Inc.

General

Signal Type Signal Value Data
Score -5.219 20 days ( 77.65 %
Last Price $1.75 -13.37 %
Performance History
7 Days
$1.98 $1.75
-11.62%
30 Days
$7.83 $1.75
-77.65%
12 Mos
$0.470 $1.75
272.34%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.49
Signal Type Signal Value Importance Data
High / Low Neutral Very Low $1.72 - $2.11
Position: 7.69% from low / 92.31% from high · Momentum: -27.24%
Trend - 3 mos -63.70 % High Width: 98.38 %
Pred. range - 3 mos $1.04 - $2.07 Low -40.30 % - 18.43 %
Volume Direction Buy High Volume: 146,907 · Direction: 1.00
Pivot Short Sell Very Low May 06, 2026 - 32 days
RSI Short Pivot Signal Buy Very Low Jun 18, 2026 - 2 days
Short MA 3 mos Buy Low Jun 16, 2026 - 4 days
Long MA 3 mos Buy Medium May 05, 2026 - 33 days
Short/Long MA 3 mos Sell Medium Apr 23, 2026 - 41 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.8
Signal Type Signal Value Importance Data
Trend - 12 mos 52.53 % Very High Width: 866.66 %
Pred. range - 12 mos $2.67 - $25.80 High 52.53 % - 1,374.45 %
Short MA 12 mos Buy Very High May 20, 2026 - 22 days
Long MA 12 mos Buy Very High Apr 22, 2026 - 42 days
Short/Long MA 12 mos Sell Very High Mar 25, 2026 - 61 days
Pivot Long Sell Low Dec 31, 2025 - 118 days
RSI Long Pivot Signal Sell Low Jun 18, 2026 - 2 days
Bollinger Buy Medium Mar 19, 2026 - 65 days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT NEXTCURE INC.
NextCure
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune sup...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE